These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11549210)

  • 1. Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997.
    Craig-McFeely PM; Acharya NV; Shakir SA
    Eur J Clin Pharmacol; 2001 Jul; 57(4):313-20. PubMed ID: 11549210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
    Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
    Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis.
    Bunnag C; Jareoncharsri P; Tunsuriyawong P; Pumhirun P; Limprasertsiri S; Chochaipanichnon L; Supiyaphun P; Kongpatanakul S
    Asian Pac J Allergy Immunol; 2000 Sep; 18(3):127-33. PubMed ID: 11270466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
    Nelson HS; Reynolds R; Mason J
    Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
    Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
    J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The systemic safety of fexofenadine HCl.
    Mason J; Reynolds R; Rao N
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():163-70; discussion 171-3. PubMed ID: 10444232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, safety and tolerability of an oral suspension of fexofenadine for children with allergic rhinitis.
    Segall N; Grubbe RE; Levy AL; Maloney MJ; Nayak AS; Kittner B; Quesada JT
    Allergy Asthma Proc; 2008; 29(4):380-5. PubMed ID: 18702885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
    Simpson K; Jarvis B
    Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis].
    López García A; Paz Martínez D; Orea Solano M; Hernández Valencia G; Ramírez García A; Ramírez Ojeda H; Sánchez Medal LF; Soda Mehry A; Velarde Domínguez T; Betancourt Suárez MA; Méndez Vera JL
    Rev Alerg Mex; 2001; 48(6):168-72. PubMed ID: 11802289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
    Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
    Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000.
    Boshier A; Wilton LV; Shakir SA
    Eur J Clin Pharmacol; 2003 Dec; 59(10):767-73. PubMed ID: 14615857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice.
    Mann RD; Pearce GL; Dunn N; Shakir S
    BMJ; 2000 Apr; 320(7243):1184-6. PubMed ID: 10784544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients].
    Degonda M; Pichler WJ; Bircher A; Helbling A
    Praxis (Bern 1994); 2002 Apr; 91(15):637-43. PubMed ID: 12014063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
    Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
    Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England.
    Twaites BR; Wilton LV; Shakir SA
    Drug Saf; 2007; 30(5):419-29. PubMed ID: 17472420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
    Prescrire Int; 1999 Feb; 8(39):11-3. PubMed ID: 10557567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England.
    Layton D; Wilton L; Shakir SA
    Drug Saf; 2009; 32(2):169-79. PubMed ID: 19236123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
    Milgrom H; Kittner B; Lanier R; Hampel FC
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):358-63. PubMed ID: 17941284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.